| |
| Issue |
Title |
| |
| No 1 (2025) |
Resolution of the Expert Council on the use of pazufloxacin |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| No 1 (2024) |
Current issues of increasing the availability of innovative therapy for the treatment of patients with non-small cell lung cancer within the Russian healthcare system |
Abstract
PDF (Rus)
|
|
K. K. Laktionov, S. K. Zyryanov, E. V. Artamonova, A. V. Smolin, E. V. Reutova, M. V. Zhuravleva, A. S. Kolbin, M. Yu. Frolov |
| |
| No 5 (2020) |
Palliative care organization in the light of updated legislation |
Abstract
PDF (Rus)
|
|
E. S. Vvedenskaya, A. V. Palekhov |
| |
| No 3 (2014) |
State of the Russian pharmaceutical industry at the present stage |
Abstract
PDF (Rus)
|
|
E. N. Hoseva |
| |
| No 2 (2014) |
Should not be allowed to ban |
Abstract
PDF (Rus)
|
|
M. G. Malaev |
| |
| No 2 (2013) |
Применение аудита с целью оптимизации закупок лекарственных средств медицинскими организациями |
Abstract
PDF (Rus)
|
|
|
| |
| No 3 (2013) |
Стандарты медицинской помощи утверждены. Что с ними делать? |
Abstract
PDF (Rus)
|
|
|
| |
| No 1 (2014) |
Analysis of drug purchases aft er the entry into force of the federal contract system |
Abstract
PDF (Rus)
|
|
M. G. Malaev |
| |
| No 1 (2014) |
Analysis of drugs procurement to ensure the provision of medical care in hospitals |
Abstract
PDF (Rus)
|
|
M. G. Malaev |
| |
| No 3 (2015) |
Medical image: casual style of behavior or a necessary element of self |
Abstract
PDF (Rus)
|
|
J. E. Vasquez Abanto, A. E. Vasquez Abanto |
| |
| No 2 (2016) |
Risk based monitoring does not reduce the cost of clinical trials |
Abstract
PDF (Rus)
|
|
I. V. Stefanov |
| |
| No 3 (2016) |
The interchangeability of drugs from line items of pharmaceutical compliance and clinical efficiency and safety |
Abstract
PDF (Rus)
|
|
N. V. Verlan, G. A. Kovalskaya, D. Ya. Zhukova, E. O. Kochkina, O. A. Solodukhina |
| |
| No 1 (2017) |
Polymorphism: the influence on the quality of drugs and actual methods of analysis |
Abstract
PDF (Rus)
|
|
G. N. Gildeeva |
| |
| No 2 (2017) |
Clinical and pharmacoeconomic aspects of anti-TNF therapy change for medical reasons |
Abstract
PDF (Rus)
|
|
U. S. Gushchina, S. K. Zyryanov, I. A. Orlikhina |
| |
| No 2 (2017) |
The problems of opioid analgesics provision. The subservice part of the iceberg |
Abstract
PDF (Rus)
|
|
A. V. Palekhov, E. S. Vvedenskaya |
| |
| 1 - 15 of 15 Items |
|
